Nicholas Investment Partners, LP Penumbra Inc Transaction History

Nicholas Investment Partners, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$174.98 - $272.83 $9.06 Million - $14.1 Million	-51,780 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$185.27 - $238.73 $8.19 Million - $10.6 Million	44,212 Added 584.2%	51,780 $10.1 Million
Q2 2020 Aug 12, 2020	SELL	$153.32 - $191.72 $2.74 Million - $3.43 Million	-17,892 Reduced 70.27%	7,568 $1.35 Million
Q1 2020 May 13, 2020	SELL	$124.34 - $193.76 $616,353 - $960,468	-4,957 Reduced 16.3%	25,460 $4.11 Million
Q4 2019 Feb 13, 2020	BUY	$134.81 - $177.8 $4.1 Million - $5.41 Million	30,417 New	30,417 $5 Million
Q1 2018 May 15, 2018	SELL	$84.6 - $126.1 $1.72 Million - $2.56 Million	-20,332 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$91.55 - $115.85 $1.98 Million - $2.51 Million	-21,632 Reduced 51.55%	20,332 $1.91 Million
Q3 2017 Nov 13, 2017	BUY	$79.65 - $90.3 $3.34 Million - $3.79 Million	41,964	41,964 $3.79 Million

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.11B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Nicholas Investment Partners, LP with notifications on news.